跳至主要内容
临床试验/NCT02825862
NCT02825862已完成不适用

Circumventing the 'Ick' Factor: a Multi-site Randomised Trial of the Effects of Omitting Affective Attitudes to Increase Intention to Become an Organ Donor

Royal College of Surgeons, Ireland8 个研究点 分布在 4 个国家目标入组 999 人开始时间: 2016年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
999
试验地点
8
主要终点
Intention to become an organ donor

研究概览

简要总结

The investigators aim to experimentally manipulate presence of questions on positive or negative affective attitudes to see if including these moderate as intention to become an organ donor. The methodology will be replicated across three international sites (RCSI Dublin, RCSI Bahrain, RCSI Perdana University).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Agree to participate

排除标准

  • Refuse to participate

研究组 & 干预措施

Replication group

No Intervention

Replication group - this group will complete the entire questionnaire, in order to replicate the findings of O'Carroll et al (2011)

Omit affective attitudes

Active Comparator

Omitting affective attitudes The intervention is the omission of all questions on affective attitudes. This group will complete a similar questionnaire to the replication group, with the same number of questionnaire items, but affective attitudes will be omitted. Dummy questions (e.g. about politics) will be substituted for these deleted questions.

干预措施: Question-behaviour effect (for affective attitudes) (Behavioral)

Omit negatively-worded items

Active Comparator

Omitting negatively-worded affective attitudes. This intervention is the omission of a subset of negatively-worded affective attitudinal items. This group will complete a similar questionnaire to the replication group, with the same number of items, but all negatively-worded affective attitudes will be omitted. Dummy questions (e.g. about politics) will be substituted for these deleted questions.

干预措施: Question-behaviour effect (negatively-worded attitudes) (Behavioral)

结局指标

主要结局

Intention to become an organ donor

时间窗: within 3 months

Mean score of two 7-point items: "I will definitely sign up for organ donation and discuss this with my family in the next few months" and "How strong is your intention to sign up for organ donation and discuss this with my family in the next few months?"

次要结局

  • Taking a donor card after the interview(Immediately at the end of the interview (i.e. that day, an average of 10-15 minutes after consenting to participate)))

研究者

发起方
Royal College of Surgeons, Ireland
申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

进行中(未招募)
不适用
Estudio aleatorizado, multicéntrico para evaluar la eficacia y seguridad de bevacizumab en combinación con letrozol comparado con letrozol solo, en mujeres postmenopáusicas con cáncer de mama localmente recurrente o metastásico con indicación de hormonoterapia como tratamiento de primera línea.Mujeres postmenopáusicas con cáncer de mama localmente recurrente o metastásico con indicación de hormonoterapia como tratamiento de primera lineaMedDRA version: 9.1Level: LLTClassification code 10006275Term: Breast metastasesMedDRA version: 9.1Level: LLTClassification code 10006212Term: Breast carcinoma recurrent
EUCTR2007-002841-19-ESGrupo Español de Investigación en Cáncer de Mama (GEICAM)378
进行中(未招募)
不适用
Estudio multicéntrico, aleatorizado que evalúa la eficacia, seguridad, tolerabilidad y farmacocinética de AEB071 combinado con tacrolimus o micofenolato mofetil (MMF) frente a un régimen control basado en tacrolimus en receptores de trasplante hepático de novo.Trasplante hepático en pacientes de novo
EUCTR2007-001776-36-ESovartis Farmacéutica S.A320
进行中(未招募)
1 期
Estudio multicentro, aleatorizado, de comparador activo y grupos paralelos para comparar el efecto sobre la cognición de la terapia adyuvante con zonisamida frente al valproato sódico. - COGZTerapia concomitante en el tratamiento de pacientes adultos con crisis parciales, con o sin generalización secundaria.MedDRA version: 9.1 Level: LLT Classification code 10065336 Term: Partial epilepsy
EUCTR2007-005313-19-ESEisai Ltd
进行中(未招募)
不适用
Estudio multicéntrico, aleatorizado, con evaluador ciego, en grupos paralelos, controlado por grupo activo, para evaluar los beneficios del cambio de tratamiento de Glatiramer Acetato o Interferón Beta 1a a Natalizumab en pacientes con esclerosis múltiple recidivante-remitente A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon B- 1a) to Natalizumab in Subjects with Relapsing Remitting Multiple Sclerosis - SURPASSEsclerosis Múltiple Recidivante-RemitenteRelapsing-Remitting Multiple SclerosisMedDRA version: 12.0Level: LLTClassification code 10063399Term: Relapsing-remitting multiple sclerosis
EUCTR2009-015556-15-ESBiogen Idec Limited1,800
进行中(未招募)
1 期
lcerative colitisMild to moderate ulcerative colitisMedDRA version: 20.0Level: PTClassification code 10009900Term: Colitis ulcerativeSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2019-003113-34-DEovartis Pharma AG45